Belotecan

DB12459InvestigationalSmall molecule

Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.

Chemical structure of Belotecan
Mechanism
Curator reviewed
Formula / weight
C25H27N3O4 · 433.508 g/mol (avg)

Resolves to

Compound
UNII27Z82M2G1NCAS256411-32-2ChEMBLCHEMBL2111084ChEBI135702PubChem6456014
Clinical / RWD
ATCL01CE04
Structure
InChIKeyLNHWXBUNXOXMRL-VWLOTQADSA-NSMILESCC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=CC1=C3CCNC(C)C)C2=O
Targets
P11387TOP1

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 7 drug categories
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Belotecan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In